Coral Laboratories Peer Comparison

Coral Laboratories Ltd. stands out as a deep value pick due to its significantly low valuation metrics despite underperformance in growth and profitability compared to its peers. With a PE ratio of just 6.97, it is undervalued relative to its earnings potential, although its financial performance metrics are currently weak.

• • Coral Laboratories has the lowest PE ratio among its peers at 6.97, indicating it may be undervalued.
• • It has no debt, giving it a debt-to-equity ratio of 0, which is favorable compared to peers with higher debt levels.
• • Despite its low valuation, Coral's growth metrics show no revenue growth or profitability, indicating challenges ahead.

• • Mankind Pharma Ltd.: Highest revenue growth YOY at 18.12% and strong profitability metrics.
• • Dr. Reddy's Laboratories Ltd.: Strong profitability with a PE of 15.50 and high ROE of 21.76%.
• • Cipla Ltd.: Good growth trajectory with revenue growth of 13.28% YOY and solid profitability.